Nobuyuki Amano

1.0k total citations
52 papers, 811 citations indexed

About

Nobuyuki Amano is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, Nobuyuki Amano has authored 52 papers receiving a total of 811 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 13 papers in Molecular Biology and 9 papers in Pharmacology. Recurrent topics in Nobuyuki Amano's work include Drug Transport and Resistance Mechanisms (20 papers), Pharmacogenetics and Drug Metabolism (8 papers) and Pharmacological Effects and Toxicity Studies (7 papers). Nobuyuki Amano is often cited by papers focused on Drug Transport and Resistance Mechanisms (20 papers), Pharmacogenetics and Drug Metabolism (8 papers) and Pharmacological Effects and Toxicity Studies (7 papers). Nobuyuki Amano collaborates with scholars based in Japan, United States and United Kingdom. Nobuyuki Amano's co-authors include Hideki Hirabayashi, Toshiya Moriwaki, Hiroshi Sugimoto, Shinji Iwasaki, S. Yamamoto, Masanori Nakakariya, Yuta Arai, Masatoshi Karashima, Toshiki Hozumi and Tsutomu Kazumi and has published in prestigious journals such as PLoS ONE, Diabetes and International Journal of Molecular Sciences.

In The Last Decade

Nobuyuki Amano

52 papers receiving 786 citations

Peers

Countries citing papers authored by Nobuyuki Amano

Since Specialization

Citations

This map shows the geographic impact of Nobuyuki Amano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuyuki Amano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuyuki Amano more than expected).

Fields of papers citing papers by Nobuyuki Amano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nobuyuki Amano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuyuki Amano. The network helps show where Nobuyuki Amano may publish in the future.

Co-authorship network of co-authors of Nobuyuki Amano

This figure shows the co-authorship network connecting the top 25 collaborators of Nobuyuki Amano. A scholar is included among the top collaborators of Nobuyuki Amano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nobuyuki Amano. Nobuyuki Amano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Involvement of Proton-Coupled Organic Cation Antiporter in Human Blood–Brain Barrier Transport of Mesoridazine and Metoclopramide 2024 ·Biological and Pharmaceutical Bulletin ·(unknown), (unknown), Masanori Nakakariya, Hideki Hirabayashi, Kazunobu Aoyama, Nobuyuki Amano, Toshiki Kurosawa, Yoshiyuki Kubo, Yoshiharu Deguchi	1
2	Construction and Functional Evaluation of a Three-Dimensional Blood–Brain Barrier Model Equipped With Human Induced Pluripotent Stem Cell-Derived Brain Microvascular Endothelial Cells 2022 ·Pharmaceutical Research ·Toshiki Kurosawa, (unknown), Yuma Tega, (unknown), (unknown), Kazunobu Aoyama, Yoshiyuki Kubo, Nobuyuki Amano, Yoshiharu Deguchi	26
3	Discovery of 1,8-naphthyridin-2-one derivative as a potent and selective sphingomyelin synthase 2 inhibitor 2020 ·Bioorganic & Medicinal Chemistry ·(unknown), (unknown), Rei Okamoto, Yuji Ishichi, Yasufumi Miyamoto, Satoshi Nishimura, Tatsuo Oikawa, Kazuki Kubo, Ryutaro Adachi, Yoshinori Satomi, Masanori Nakakariya, Nobuyuki Amano, Masahiro Kamaura, Nobuyuki Matsunaga	9
4	Direct Drug Delivery of Low-Permeable Compounds to the Central Nervous System Via Intranasal Administration in Rats and Monkeys 2019 ·Pharmaceutical Research ·Shinji Iwasaki, S. Yamamoto, (unknown), Kimio Tohyama, Yohei Kosugi, (unknown), Teruki Hamada, (unknown), Yasushi Fujioka, Hideki Hirabayashi, Nobuyuki Amano	27
5	Enhanced pulmonary absorption of poorly soluble itraconazole by micronized cocrystal dry powder formulations 2017 ·European Journal of Pharmaceutics and Biopharmaceutics ·Masatoshi Karashima, (unknown), S. Yamamoto, Yuta Arai, Katsuhiko Yamamoto, Nobuyuki Amano, Yukihiro Ikeda	50
6	Design and synthesis of a novel series of orally active, selective somatostatin receptor 2 agonists for the treatment of type 2 diabetes 2017 ·Bioorganic & Medicinal Chemistry ·(unknown), Shigekazu Sasaki, (unknown), Jun Kunitomo, Yasufumi Miyamoto, Hidenori Abe, Naohiro Taya, Satoru Oi, Masanori Watanabe, (unknown), Masatoshi Hazama, Shin‐Ichi Niwa, Saku Miyamoto, (unknown), (unknown), Nobuyuki Amano, Shin-ichi Matsumoto, Shin-ichiro Matsunaga	5
7	Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling of the Glucagon-Like Peptide-1 Receptor Agonist Exenatide to Characterize Its Antiobesity Effects in Diet-Induced Obese Mice 2017 ·Journal of Pharmacology and Experimental Therapeutics ·Shinji Iwasaki, Teruki Hamada, (unknown), (unknown), (unknown), (unknown), Nobuyuki Amano	11
8	Novel Application of Cultured Epithelial Autografts (CEA) with Expanded Mesh Skin Grafting Over an Artificial Dermis or Dermal Wound Bed Preparation 2017 ·International Journal of Molecular Sciences ·Sadanori Akita, Kenji Hayashida, Hiroshi Yoshimoto, Masaki Fujioka, (unknown), (unknown), (unknown), (unknown), Kazuo Kobayashi, Kuniaki Anraku, Ryuichi Murakami, Akiyoshi Hirano, (unknown), (unknown), Nobuyuki Amano, Hiroshi Nakagawa	18
9	Appropriate risk criteria for OATP inhibition at the drug discovery stage based on the clinical relevancy between OATP inhibitors and drug-induced adverse effect 2016 ·Drug Metabolism and Pharmacokinetics ·Masanori Nakakariya, Akihiko Goto, Nobuyuki Amano	8
10	Evaluation of Acid Tolerance of Drugs Using Rats and Dogs Controlled for Gastric Acid Secretion 2015 ·Journal of Pharmaceutical Sciences ·Yohei Kosugi, S. Yamamoto, (unknown), (unknown), (unknown), Yasushi Fujioka, Nobuyuki Amano	9
11	Optimization of a novel series of N-phenylindoline-5-sulfonamide-based acyl CoA:monoacylglycerol acyltransferase-2 inhibitors: Mitigation of CYP3A4 time-dependent inhibition and phototoxic liabilities 2015 ·Bioorganic & Medicinal Chemistry ·Kenjiro Sato, (unknown), Osamu Kubo, (unknown), Takeshi Yoshikawa, Masahiro Kamaura, Masanori Nakakariya, Nobuyuki Amano, Ryutaro Adachi, Toshiyuki Maki, (unknown), Shiro Takekawa, Tomoyuki Kitazaki, Tsuyoshi Maekawa	10
12	Retrospective Analysis of P-Glycoprotein–Mediated Drug-Drug Interactions at the Blood-Brain Barrier in Humans 2013 ·Drug Metabolism and Disposition ·Hiroshi Sugimoto, Hideki Hirabayashi, Nobuyuki Amano, Toshiya Moriwaki	16
13	Design, synthesis, and structure–activity relationships of novel spiro-piperidines as acetyl-CoA carboxylase inhibitors 2012 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Takashi Yamashita, Asato Kina, Masaaki Funata, Atsushi Mizukami, Masako Sasaki, Akiyoshi Tani, Miyuki Funami, Nobuyuki Amano, K. Fukatsu	46
14	Symmetrical approach of spiro-pyrazolidinediones as acetyl-CoA carboxylase inhibitors 2012 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Takashi Yamashita, Asato Kina, Michiko Tawada, Satoshi Endo, Atsushi Mizukami, Masako Sasaki, Akiyoshi Tani, (unknown), (unknown), Naoki Furuyama, Miyuki Funami, Nobuyuki Amano, K. Fukatsu	35
15	In Vivo Biliary Clearance Should Be Predicted by Intrinsic Biliary Clearance in Sandwich-Cultured Hepatocytes 2011 ·Drug Metabolism and Disposition ·Masanori Nakakariya, Midori Ono, Nobuyuki Amano, Toshiya Moriwaki, Kazuya Maeda, Yuichi Sugiyama	29
16	Development of a quantification method for digoxin, a typical P-glycoprotein probe in clinical and non-clinical studies, using high performance liquid chromatography–tandem mass spectrometry: The usefulness of negative ionization mode to avoid competitive adduct-ion formation 2011 ·Journal of Chromatography B ·Hideki Hirabayashi, Hiroshi Sugimoto, Shin-ichi Matsumoto, Nobuyuki Amano, Toshiya Moriwaki	23
17	Establishment of In Vitro P-Glycoprotein Inhibition Assay and Its Exclusion Criteria to Assess the Risk Of Drug–Drug Interaction at the Drug Discovery Stage 2011 ·Journal of Pharmaceutical Sciences ·Hiroshi Sugimoto, Shin-ichi Matsumoto, (unknown), Shin‐Ichi Niwa, Hideki Hirabayashi, Nobuyuki Amano, Toshiya Moriwaki	35
18	Possible roles of mast cell-derived chymase for skin rejuvenation 2008 ·Lasers in Medical Science ·Nobuyuki Amano, Shinji Takai, Denan Jin, Koichi Ueda, Mizuo Miyazaki	10
19	Asymmetric Intestinal First-Pass Metabolism Causes Minimal Oral Bioavailability of Midazolam in Cynomolgus Monkey 2007 ·Drug Metabolism and Disposition ·Tomohiro Nishimura, Nobuyuki Amano, Yoshiyuki Kubo, Midori Ono, Yukio Kato, Hisashi Fujita, (unknown), Akira Tsuji	38
20	Lipid Accumulation in the Liver of Rats Fed a Soy Protein Isolate Diet with Excess Cystine, and its Prevention by Methionine or Choline 1992 ·Bioscience Biotechnology and Biochemistry ·Yoritàka Aoyama, Tomohiro Ishikawa, Nobuyuki Amano, Akira Yoshida	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact